Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

Clinical trial NCT06632730 · COMPLETED

Trial details

NCT number: NCT06632730
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Spinal Muscular Atrophy Type I Spinal Muscular Atrophy Type II

Start date: 2023-07-05
Primary completion: 2023-11-20
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.